← index / pharma + device

Pharma — Demand + RWE

SKU forecast, real-world evidence cohort builder, supply chain, pharmacogenomics.

pharma.averra.ae / demand
  • ◆ Demand
  • RWE
  • Trials
  • Supply
  • Models
  • API
  • Submissions
  • PGx
  • Insights
  • Billing
Demand · Semaglutide 1.0mg · UAE
de-identified · federated learning · k ≥ 20
Export to SAP ERP

18-month demand cone · by region

today Oct '25Mar '26Nov '26Apr '27 units (k)
Dubai · ▲ 22% Abu Dhabi · ▲ 18% RAK · ▼ 4%

Regional anomalies

RegionExp.Act.Driver
Dubai · Jumeirah2,4002,920new clinic
Dubai · Al Barsha1,2001,100seasonal
RAK640420stockout risk
Sharjah1,8401,910—

RWE cohort · T2DM + BMI>30

n = 2,184 · k-ok
GLP-1 standard
HR 0.64 · 95% CI 0.51–0.79

Supply chain · stockout risk

RAK central · ● crit · 9d
Al Ain #2 · ◑ high · 14d
Dubai South · ◐ mod · 21d
Sharjah hub · ○ low · 42d
cold-chain · all green

PGx · ME population

CYP2C19 poor · 12.4%
CYP2D6 rapid · 8.1%
SLCO1B1 var. · 18%
HLA-B*57:01 · 1.8%
calibrated GCC cohort · n=14,280
↳ Federated-learning banner: data never leaves Averra. Only model updates ship.
↳ Patient contact is only via consent-broker — pharma never gets identity.
↳ KM curves always show HR + 95% CI; never point estimate alone.
← back to index